Swetha Byravan

Swetha Byravan

Auto-generated profile, based on publicly available information

Swetha Byravan

Department of Rheumatology, University Hospitals of Birmingham, Birmingham, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2024 in Expert Opinion on Investigational Drugs
Verified
Journal Article
Closed access
SBSwetha Byravan
Swetha Byravan
HSHarini Samarasinghe
Harini Samarasinghe
JYJack Shi Jie Yuan
Jack Shi Jie Yuan
STSyed Haider Tahir
Syed Haider Tahir
AMArumugam Moorthy
Arumugam Moorthy
HTHasan Tahir
Hasan Tahir
IL-17 has been described as a pro-inflammatory cytokine that is relevant in the seronegative spondylarthritides with IL-17 targeted therapies being licensed for their treatment.There is evidence to demonstrate that IL-17 is found in RA joints and contributes to the pro-inflammatory cascade. This results in synovial hyperplasia and osteoclastogenesis thus causing joint destruction and bony erosions. This review article summarizes trials that have studied the use of IL-17 targeted therapies in RA patients who have failed conventional synthetic disease-modifying therapy (C-DMARDS) and biologic DMARDS. The trials that have studied IL-17 inhibitors in RA patients have only shown a modest improvement in disease activity. In several trials, the primary endpoint was not achieved whilst in others, when comparing with existing licensed biologics for RA, did not demonstrate any superiority.Tissue Necrosis Factor-alpha (TNF-α) likely plays more of a pivotal role in the pathogenesis of RA with IL-17 having a synergistic effect. Therefore, in our opinion, IL-17 inhibitors as an independent therapy for RA are less likely to provide a cost-effective benefit. There may be scope to potentially combine it with TNF-α-inhibitors (TNF-i), but this requires further research especially with the potential concerns related to increased immunosuppression.

1 January 2021 in Journal of Patient Experience
Verified
Journal Article
Open access
PDF file
SBSwetha Byravan
Swetha Byravan
KSKehinde Sunmboye
Kehinde Sunmboye
The pandemic has resulted in many changes to health services, one of these is the shift from face-to-face consultations to virtual ones across all specialities. As the pandemic continues with no end in sight it seems that virtual consultations will continue for the foreseeable future. In this article, we analyze the patient feedback so far to virtual consultations in a large tertiary center and use this opportunity to reflect on this new service. We have a particular interest in musculoskeletal services as this is largely an outpatient-based speciality and the pandemic has consequently resulted in significant changes in practice. We also consider whether virtual clinics is a sustainable service post-COVID-19 and the benefits and disadvantages of this.

1 July 2021 in Journal of Experimental Pharmacology
Verified
Journal Article
Open access
HTHasan Tahir
Hasan Tahir
SBSwetha Byravan
Swetha Byravan
AFArmin Fardanesh
Armin Fardanesh
AMArumugam Moorthy
Arumugam Moorthy
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articles or submit your research for publishing.

1 February 2021 in International Journal of Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
SBSwetha Byravan
Swetha Byravan
AFArmin Fardanesh
Armin Fardanesh
HTHasan Tahir
Hasan Tahir
AMArumugam Moorthy
Arumugam Moorthy
Click on the article title to read more.

6 July 2022 in Musculoskeletal Care
Verified
Journal Article
Open access
PDF file
SBSwetha Byravan
Swetha Byravan
SJSindhuja Jothimurugan
Sindhuja Jothimurugan
AMArumugam Moorthy
Arumugam Moorthy
Background The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is a patient reported outcome (PRO) used in the monitoring of axial spondyloarthropathy (axSpA). It is completed by the patient and based on their assessment of disease severity and therefore quite a subjective measure of disease (1). There has been research around the relationship between ethnicity and patient perception in Rheumatology. Many studies have demonstrated that non-Caucasian patients especially South Asians are less likely to engage with patient education, abandon their disease modifying therapy early and have more mistrust with the medical establishment (2). Quite a large population study in America examining axSpA severity in Caucasians, Afro-Caribbean’s and Latinos found Afro-Caribbean and Latino patients to score themselves higher on BASDAI compared to Caucasians (3). With Leicester being such a diverse area, with a particularly high South Asian population we took this opportunity to investigate whether there were ethnic variations in disease severity. Objectives The aim was to investigate whether there is a relationship between patient-reported outcome BASDAI and ethnicity. The secondary aim was to investigate the relationship between ethnicity and radiographic findings and extra-articular manifestations. Methods Data was collected by retrospective analysis of axSpA patients attending University of Leicester (UHL) axSpA services. Inclusion criteria entailed a diagnosis of axSpA with a documented BASDAI within a year of MRI spine + sacroiliac joints, prior to starting any biological treatment. Data of 149 patients was collected on demographic characteristics, extra-articular manifestations (uveitis, inflammatory back pain, enthesitis, peripheral arthritis, dactylitis, psoriasis, and inflammatory bowel disease), family history, response to NSAIDs, and HLA-B27 status. Data was analysed using Statistical Package for the Social Sciences (SPSS) software to assess the relationship between ethnicity and collected data using Pearson’s chi squared. Results Of the 149 patients 68% were White Caucasian, 30% Asian and 1% Black. The average age was 43 and 66% were male and 34% female. The mean BASDAI was 6.5, there was no observable correlation between BASDAI and ethnicity (p=0.668). There was no significant relationship between ethnicity and active sacroiliitis (p=0.926), chronic sacroiliitis (p= 0.218) or axial disease (p=0.307). 64 Caucasian patients were HLA-B27 positive compared with 27 Asian and no Black patients were positive however there was no statistical correlation between ethnicity and HLA-B27 (p=0.383). Overall, Caucasians consistently had a greater incidence of extra-articular manifestations compared with non-Caucasians however no significant p values were observed here or with response to NSAIDs, family history or familial HLA-B27 and BASDAI scores, results are summarised in Table 1. Conclusion This study did not demonstrate statistically significant finding of ethnic variations in BASDAI. There was also no relationship between ethnicity and other data sets. However, the main limitation of this study is the sample size and unequal representation of ethnicities with there being far more Caucasians than non-Caucasian patients. Though this study provides an insight into quite a limited area of research, a larger study with equal ethnic patient population samples is required to obtain more meaningful results. References [1]Zochling J. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken). 2011;63(11):47-58. [2]Kumar K, Klocke R. Ethnicity in rheumatic disease. Clin Med (Lond). 2010;10(4):370-372. [3]Jamalyaria F, Ward M, Assassi S, Learch T, Lee M. Gensler L et al. Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups. Clin Rheumatol. 2017;36(10):2359-2364. Disclosure of Interests None declared

4 November 2022 in Clinical Radiology
Verified
Journal Article
Closed access
PDF file
SBSwetha Byravan
Swetha Byravan
ASAmit Shah
Amit Shah
FJFarhan Javaid
Farhan Javaid
MKMerriam Kadacheeni
Merriam Kadacheeni
PPPrashanth Patel
Prashanth Patel
VPVeena Patel
Veena Patel